Concepedia

H.-P. Feng

HF

Statistics

Publications

2

Citations

84

H-Index

2

Active since

2013

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

H.-P. Feng is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in viral hepatitis, hepatology, and hepatitis.

Top concepts

Publications per year

2013–2015

2

Publications

2

O006 : C-swift: grazoprevir/elbasvir + sofosbuvir in cirrhotic and noncirrhotic, treatment-naive patients with hepatitis C virus genotype 1 infection, for durations of 4, 6 or 8 weeks and genotype 3 infection for durations of 8 or 12 weeks

Fred Poordad, Eric Lawitz, Julio Gutiérrez et al. · Journal of Hepatology · 2015 · 45 citations

, , +12

Pharmacokinetic Evaluation of the Interaction between Hepatitis C Virus Protease Inhibitor Boceprevir and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Atorvastatin and Pravastatin

E.G.J. Hulskotte, H.-P. Feng, Feng Xuan et al. · Antimicrobial Agents and Chemotherapy · 2013 · 39 citations · Full text

, , +14

1–2 of 2